Last Updated: November 10, 2026

Details for Patent: 3,732,340

Name: Drug Patent Intelligence for US Patent 3732340
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Summary for Patent: 3,732,340

Title:	N',o-propylene phosphoric acid ester diamides
Abstract:	THERE ARE PROVIDED NEW N-SUBSTITUTED AMIDES AND ESTERAAMIDES OF PHOSPHORIC ACID OF THE FORMULA I: O<(-P(=O)(-X2)-N(-R1)-(C(-Z)2)M-) WHEREIN R1 IS A LOWER ALKYL GROUP HAVING FROM 1 TO 4 CARBON ATOMS BEING SUBSTITUTED WITH ONE OR SEVERAL HALOGEN ATOMS, Z IS HYDROGEN OR A LOWER ALKYL GROUP HAVING FROM 1 TO 4 CARBON ATOMS, M IS 2 OR 3 AND X2 IS THE ETHYLENE IMINO GROUP OR THE GROUP HAVING THE FORMULA: CL-(-C(-Z)2)M-N-R WHEREIN R IS HYDROGEN OR A LOWER ALKYL GROUP HAVING FROM 1 TO 4 CARBON ATOMS WHICH MAY BE SUBSTITUTED WITH A CHLORINE ATOM OR A HYDROXY GROUP, AND Z AND M HAVE THE ABOVE-GIVEN MEANING. EACH OF THESE PRODUCTS IS USEFUL AS A CYTOSTATICALLY EFFECTIVE COMPOUND AND IS USED IN THE MANNER EXEMPLIFIED HEREINAFTER WITH RESPECT TO TEST ANIMALS, E.G. RATS, ACCORDING TO KNOWN TECHNIQUES FOR ADMINISTERING TEST DOSAGES.
Inventor(s):	H Arnold, N Brock, F Bourseaux, H Bekel
Assignee:	ASTA WERKE AG DT , Asta Medica GmbH
Application Number:	US00106569A
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 3,732,340

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 3,732,340

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	274001	⤷ Start Trial
Belgium	700711	⤷ Start Trial
Switzerland	509353	⤷ Start Trial
Switzerland	510699	⤷ Start Trial
Switzerland	512520	⤷ Start Trial
Germany	1645921	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.